For millions of breast cancer survivors, the conclusion of active treatment—surgery, chemotherapy, and radiation—is often viewed as...
NORMAN, OKLAHOMA – In a significant stride against one of cancer’s most formidable adversaries, new research emanating...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) The landscape of medical treatment is...
OCTOBER 31, 2024 — As the global "Pink October" campaigns draw to a close, the metastatic breast...
TORONTO, ON — As medical advancements continue to improve the survival rates for breast cancer, the healthcare...
In the wake of the most significant global health crisis in a century, the World Health Organization...
The biotechnology sector in 2026 has witnessed a remarkable resurgence in public market confidence, punctuated most recently...
Executive Summary: Advancing the "Leave-Nothing-Behind" Philosophy Teleflex Incorporated has achieved a significant regulatory milestone as the US...
In a move that underscores the shifting geography of pharmaceutical innovation, Swiss healthcare giant Roche has solidified...
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
